Zaoanxin Integrated Metabolic Health Assessment Service
“Zaoanxin” offers accurate quantitative analysis targeting four small molecule metabolites
With its long-term commitment to boosting public health as its responsibility, Human Metabolomics Institute, Inc. has launched Zaoanxin Integrated Metabolic Health Assessment Service. With just tiny amount of blood, the service offers accurate quantitative analysis targeting four small molecule metabolites at a time, which is more efficient and convenient than four separate tests by traditional physical examinations.
Using a specific AI-enabled auxiliary diagnostic software tool, Zaoanxin Integrated Metabolic Health Assessment Service conducts comparative analysis based on big data of healthy people and patients, and then associates metabolic patterns with certain diseases, so that it can offer multi-dimensional assessment on gastrointestinal health, and the risk of fibrosis and cirrhosis in liver, diabetes, and cardiovascular diseases at the same time simultaneously.
The service can also analyze the changes of health indicators during the monitoring period and predict changes in these indicators for future.
Superiorities of Zaoanxin
- Using unified data analytics, the service can compare data from different platforms and different tests, analyze the changes of health indicators during the monitoring period, and predict changes in these indicators for future.
- It offers accurate quantitative analysis targeting four small molecule metabolites at a time, which is faster, more convenient, more efficient and cost-effective than four separate tests by traditional physical examinations.
- It offers quantitative analysis targeting four small molecule metabolites at a time, so that it can make a comprehensive judgment on the health conditions of a person from multiple perspectives.
- By conducting comparative analysis based on big data of healthy people and patients, the service associates metabolic patterns with certain diseases, so that it can assess health indicators and predict the incidence risk of diseases, as well as offers independent multi-dimensional assessment of the incidence risk of many diseases simultaneously.
- Tiny amount of blood is required for the service to generate at most eight reports on health indicators and disease risk assessment based on different dimensions.
- The service is unique, without any competing product on the market adopting similar testing model. Its cutting-edge technology makes it difficult to be copied by other competitors.
Eight health reports can be generated based on one test
Assessment Reports
- Gastrointestinal health assessment
- Early risk assessment of liver fibrosis and cirrhosis
- Early risk assessment of diabetes
- Early risk assessment of cardiovascular diseases
- Analysis of the balance of amino acid metabolism
- Analysis of the balance of bile acid metabolism
- Analysis of the balance of fatty acid metabolism
- Neurotransmitter assay
